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Abstract
Objective: To validate a brief measure of vaccination confidence using a large, nationally
representative sample of parents.
Methods: We analyzed weighted data from 9018 parents who completed the 2010 National
Immunization Survey–Teen, an annual, population-based telephone survey. Parents
reported on the immunization history of a 13- to 17-year-old child in their households for
vaccines including tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal, and
human papillomavirus vaccines. For each vaccine, separate logistic regression models
assessed associations between parents' mean scores on the 8-item Vaccination Confidence
Scale and vaccine refusal, vaccine delay, and vaccination status. We repeated analyses for
the scale's 4-item short form.
Results: One quarter of parents (24%) reported refusal of any vaccine, with refusal of
specific vaccines ranging from 21% for human papillomavirus to 2% for Tdap. Using the full
8-item scale, vaccination confidence was negatively associated with measures of vaccine
refusal and positively associated with measures of vaccination status. For example, refusal
of any vaccine was more common among parents whose scale scores were medium (odds
ratio, 2.08; 95% confidence interval, 1.75–2.47) or low (odds ratio, 4.61; 95% confidence
interval, 3.51–6.05) versus high. For the 4-item short form, scores were also consistently
associated with vaccine refusal and vaccination status. Vaccination confidence was
inconsistently associated with vaccine delay.
Conclusions: The Vaccination Confidence Scale shows promise as a tool for identifying
parents at risk for refusing adolescent vaccines. The scale's short form appears to offer
comparable performance.
Keywords: adolescent health, human papillomavirus vaccine, immunization,
meningococcal vaccine, tetanus vaccine, vaccine hesitancy

What's New
Using data from a nationally representative sample of parents, we found that
mean scores on the Vaccination Confidence Scale were consistently associated with
vaccine refusal and vaccination status across the adolescent platform. The scale's
4-item short form demonstrated comparable performance.
A sizable minority of parents in the United States have concerns that lead
them to refuse or intentionally delay certain vaccines for their children.1 Although
forgone vaccination has been studied most extensively with regard to vaccines in
the early childhood schedule,1–5 the problem is also highly relevant to the
adolescent platform: tetanus, diphtheria, and acellular pertussis (Tdap);
meningococcal; and human papillomavirus (HPV) vaccines. For example, almost
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one-third of parents (31%) report having refused or delayed HPV vaccine for an
age-eligible daughter, and not surprisingly, parental refusal and delay are
associated with lower HPV vaccination coverage.6 The most common reasons for
refusing or delaying HPV vaccine are concerns about long-term adverse effects,
believing the vaccine is not needed, and uncertainty about vaccine effectiveness.6
National prevalence estimates are not currently available for the refusal and delay
for Tdap and meningococcal vaccines. However, parents of unvaccinated children
commonly report that they have not gotten these vaccines for their children as a
result of lack of information or believing the vaccines are not needed.7 Taken
together, these findings suggest that parents' vaccination beliefs are important for
understanding their participation in adolescent immunization programs.
Efforts to intervene on parents' vaccination beliefs so as to prevent refusal
and delay of adolescent vaccines are currently hindered by a lack of valid and
reliable measures for identifying populations most at risk for these behaviors.
Although researchers, including this study team, have developed scales to assess
vaccination beliefs with regard to early childhood vaccines or HPV vaccine
specifically,8,9 the field currently lacks a composite measure capable
of characterizing adolescent vaccination beliefs more holistically across vaccine
types. To be most useful, a measure would be validated with regard to adolescents'
vaccination status as well as with the specific behaviors of parental vaccine refusal
and delay. The ideal measure would also be very brief so as to minimize participant
burden and the considerable expense that large surveys typically incur.
To develop such a tool, we sought to validate the Vaccination Confidence
Scale, an 8-item, 3-factor measure of vaccination beliefs that our prior research has
shown to be highly reliable across diverse populations.10 Using a nationally
representative sample of parents of adolescents, this study aimed to assess
associations between Vaccination Confidence Scale scores and vaccine refusal,
vaccine delay, and vaccination status. To increase the utility of the scale, we also
sought to establish meaningful thresholds for categorizing scale scores as indicating
low, medium, or high vaccination confidence. Finally, because of the premium
placed on scale length, we assessed the performance of each of the scale's 3
factors to identify possible short forms of our measure. By creating a brief,
validated measure of vaccination beliefs, this study aimed to provide a practical tool
for understanding and intervening on forgone vaccination among parents of
adolescents.

Methods
Participants and Data Source
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Data came from the 2010 National Immunization Survey (NIS)-Teen, an
annual, population-based survey involving 2 phases of data collection. In an initial
household telephone survey, parents and guardians contacted through random-digit
dialing provided immunization-related information about a randomly selected 13- to
17-year-old child in their household. Because most respondents reported being a
parent of the child in question, we refer to these respondents collectively as
parents. For children whose parents gave consent, a follow-up, mail-based survey
of health care providers assessed vaccination status.
The household response rate for the 2010 NIS-Teen was 58%.11 We drew our
sample from 11,754 parents who completed the Parental Attitudes Module, a
special set of questions included in the 2010 NIS-Teen for 2 quarters of data
collection. We excluded parents who had missing data on parental attitudes or
vaccination behaviors (n = 2129) or who completed the survey in a language other
than English (n = 607). Our primary analytic sample consisted of the remaining
9018 parents. For analyses involving vaccination status, we used a secondary
analytic sample consisting of the subset of 7173 parents with provider-reported
vaccination status.
The National Center for Health Statistics (NCHS) research ethics review
board approved data collection for the 2010 NIS-Teen. Analysis of deidentified data
from the survey is exempt from the federal regulations for the protection of human
research participants. We accessed data from the Parental Attitudes Module through
the NCHS Research Data Center because these restricted variables are not included
in the public-use data set. Analysis of restricted data through the NCHS Research
Data Center was approved by the NCHS Ethics Review Board. The University of
North Carolina institutional review board determined that this study was exempt
from further review.

Measures
The Parental Attitudes Module assessed parents' beliefs about vaccination
with survey items conceptualized using the Health Belief Model.12 Items used an
11-point response scale ranging from 0 (strongly disagree) to 10 (strongly agree).
In a prior study, we used 8 of 11 available items to develop the Vaccination
Confidence Scale (Fig. 1). Consisting of 3 factors assessing the benefits of
vaccination (ie, Benefits), the harms of vaccination (Harms), and trust in health
care providers (Trust), the scale showed good fit both overall (comparative fit index
= 0.97; root mean square error of approximation = 0.06) and across subgroups of
7 demographic factors, including race/ethnicity, poverty status, and child's age.10
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Figure 1. Factor structure of Vaccination Confidence Scale.
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Additional items in the Parental Attitudes Module assessed parents' history of
refusing or delaying vaccines. Parents first indicated whether they had ever
“refused or decided not to get a vaccination” for their child (ie, any vaccine
refusal); this item was not specific to adolescent vaccination. For those reporting
any refusal, separate items assessed whether parents had refused Td/Tdap, a
meningitis shot, or an HPV shot. Parents next reported whether they had ever
“delayed or put off getting a vaccination” for their child (ie, any vaccine delay). For
those reporting any delay, parents indicated which vaccines they had delayed as
for vaccine refusal. All items on refusal and delay used yes/no response options.
The 2010 NIS-Teen household survey assessed participant characteristics
including the child's age, sex, race/ethnicity, and eligibility for the Vaccines for
Children program (Table 1). Vaccines for Children is a federally funded program
that provides free vaccines to vulnerable populations, including uninsured and
Medicaid-eligible youth.13 Respondents indicated their relationship to the child, the
age and educational attainment of the child's mother, and the annual income and
geographic location of the household. NCHS analysts classified households as
urban, suburban, or rural on the basis of metropolitan statistical areas.14
Table 1. Characteristics of 9018 Participants∗
Characteristic

N (%)

Child characteristics
Age
13 y

1755 (20)

14 y

1800 (20)

15 y

1843 (20)

16 y

1878 (21)

17 y

1742 (19)

Sex
Male

4726 (51)

Female

4292 (49)

Race/ethnicity
Non-Hispanic white

6418 (65)

Non-Hispanic black

1068 (16)

Hispanic

800 (11)

Other

732 (7)
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Characteristic

N (%)

Vaccines for children eligibility
Yes

1856 (23)

No

5303 (55)

Not reported

1859 (21)

Parent characteristics
Relationship to child
Mother/female guardian

7073 (77)

Father/male guardian

1503 (17)

Other

442 (6)

Parent's age
≤34 y

621 (7)

35–44 y

3617 (43)

≥45 y

4780 (50)

Parent's education
≤12 y

2409 (35)

Some college, no degree

2696 (27)

College degree or more

3913 (39)

Household characteristics
Region
Northeast

1783 (19)

Midwest

1952 (23)

South

3360 (38)

West

1923 (21)

Annual income
Below poverty level†

1024 (14)

Above poverty level, ≤$75,000 4017 (42)
>$75,000

3619 (39)

Not reported

358 (4)

MSA
Urban

3452 (34)

Suburban

3448 (48)
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Characteristic
Rural

N (%)
2118 (18)

MSA indicates metropolitan statistical area.
∗
Data are presented as raw frequencies and weighted percentages.
Percentages may not total 100% as a result of rounding.
†
Poverty level based on 2009 US Census poverty threshold.
The 2010 NIS-Teen provider survey assessed the child's vaccination status.
Providers used medical records to indicate the dates on which the child received
vaccine doses, including doses of Td/Tdap, meningococcal, and HPV vaccines. NCHS
analysts then used vaccination dates to determine whether the child was up to date
for Td/Tdap, meningococcal vaccine, and HPV vaccine initiation (≥1 dose) and
completion (3 doses). Because data collection for the 2010 NIS-Teen occurred
before the addition of HPV vaccine to boys' routine immunization schedule, we
limited all analyses related to HPV vaccine to girls.15

Statistical Analyses
Using the Vaccination Confidence Scale, we reverse-coded negative attitudes
in the Harms factor and calculated mean scores for each parent by averaging
responses for all 8 items. The resulting scores had a possible range of 0 to 10, with
higher scores indicating more positive attitudes about vaccination. To investigate
the relationship between overall vaccination confidence and vaccination behavior,
we used separate bivariate logistic regression models to assess the association
between mean scale scores and vaccine refusal or delay reported for any vaccine,
or Td/Tdap, meningococcal, or HPV vaccines specifically. We also used bivariate
logistic regression to assess the association between mean scale scores and
vaccination status for Td/Tdap, meningococcal vaccine, and HPV vaccine initiation
and completion. For statistically significant (P < .05) associations, we reran each
model controlling for demographic factors that we found were associated with
vaccine refusal or delay: child's race/ethnicity, mother's educational attainment,
and annual household income.
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We calculated mean scores for the Benefits, Harms, and Trust factors from
the scale by averaging the item responses within each factor. We used logistic
regression to assess the association between mean factor scores and vaccine
refusal, vaccine delay, and vaccination status in the manner described above. We
used the findings of these analyses to identify those factors most strongly and
consistently associated with refusal, delay, and vaccination status; we considered
these factors as candidates for creating a short form of our scale.
We next established thresholds for our scale with regard to vaccine refusal.
The purpose of this analysis was to provide cut points for researchers wishing to
use our scale to stratify analyses on the basis of risk of refusal. We graphed the
percentage of parents reporting any vaccine refusal within each 1-point interval in
mean scores, using all 8 items. We visually inspected the graph to identify changes
in slope that may indicate natural cut-points. Using the resulting cut points, we
categorized mean scale and factor scores into low, medium, and high values. We
used logistic regression to assess associations between these categories and any
vaccine refusal. We repeated these procedures for the factors previously identified
as promising candidates for a short form.
Our analyses used survey weights developed by the NCHS for the primary
and secondary samples to obtain nationally representative estimates. We report
raw frequencies and weighted means, percentages, and odds ratios. Conducted in
SAS 9.3 (SAS Institute, Cary, NC), all statistical tests were 2-tailed with a critical
alpha of 0.05.

Results
Sample Characteristics
Most parents reported on children who were non-Hispanic white (65%), nonHispanic black (16%), or Hispanic (11%) (Table 1). The sample included similar
numbers of children by age (mean, 15.1 years) and sex (51% male). Most
respondents were mothers or female guardians (77%). On indicators of
socioeconomic status, about one-third of children had mothers with a high school
degree or less education (35%), and over one-tenth (14%) lived in poverty.

Scale Validation
Vaccination Confidence
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Using response scales of 0 to 10, parents reported high overall vaccination
confidence. The mean score for the full, 8-item scale was 8.19 (standard error
[SE] = 0.03) after reverse coding for Harms. Factor score means were 8.49 (SE =
0.03) for Benefits, 3.31 (SE = 0.04) for Harms (without reverse coding), and 9.06
(SE = 0.03) for Trust.

Vaccine Refusal
About one-quarter of parents (24%) reported having refused any vaccine for
their child, with the prevalence of vaccine-specific refusal being 21% for HPV
vaccine (girls only), 5% for meningococcal vaccine, and 2% for Tdap (Table 2). For
the overall scale, vaccination confidence was negatively associated with refusal of
any vaccine, such that every 1-point increase in mean score corresponded with a
4% decrease in the odds of refusal (odds ratio [OR], 0.96; 95% confidence interval
[CI], 0.95–0.96). Vaccination confidence was also negatively associated with
refusal of Tdap, meningococcal, and HPV vaccines.
Table 2. Parent-reported Vaccine Refusal: Multivariable Associations With Scale and
Factor Score Means (n = 9018)∗
Scale
Refused
Characteristic
n (%)

(8 items)

Factors
Benefits (4
items)

Harms (2 items)

Trust (2
items)

OR
Mean OR (95% Mean OR (95% Mean OR (95% Mean
(95%
(SE)
CI)
(SE)
CI)
(SE)
CI)
(SE)
CI)

Any vaccine
Yes

2186
(24%)

0.96
7.62
(0.95,
(0.05)
0.96)

0.94
7.84
(0.93,
(0.06)
0.95)

1.04
3.99
(1.02,
(0.08)
1.06)

No

6832
(76%)

8.36
8.70
3.10
9.16
Reference
Reference
Reference
(0.03)
(0.03)
(0.05)
(0.03)

Yes

174 (2%)

0.93
6.39
(0.92,
(0.22)
0.94)

No

8844
(98%)

8.21
8.53
3.28
9.08
Reference
Reference
Reference
(0.03)
(0.03)
(0.04)
(0.03)

424 (5%)

0.94
6.87
(0.93,
(0.13)
0.95)

8.76
—
(0.06)

Tdap
0.91
6.39
(0.89,
(0.26)
0.94)

1.09
5.49
(1.04,
(0.25)
1.14)

8.28
—
(0.27)

Meningococcal
Yes

0.90
6.81
(0.88,
(0.16)
0.91)

4.63
—
(0.21)

8.50
—
(0.16)
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Scale
Refused
Characteristic
n (%)

(8 items)

Factors
Benefits (4
items)

Harms (2 items)

Trust (2
items)

OR
Mean OR (95% Mean OR (95% Mean OR (95% Mean
(95%
(SE)
CI)
(SE)
CI)
(SE)
CI)
(SE)
CI)

8594
(95%)

8.24
8.56
3.26
Reference
Reference
(0.03)
(0.03)
(0.04)

9.09
(0.03)

Yes

741
(21%)

0.96
7.58
(0.94,
(0.08)
0.97)

8.72
—
(0.13)

No

2806
(79%)

8.34
8.70
3.20
9.17
Reference
Reference
Reference
(0.05)
(0.06)
(0.08)
(0.04)

No
HPV†

0.94
7.83
(0.92,
(0.11)
0.96)

1.04
4.07
(1.01,
(0.13)
1.07)

SE indicates standard error; OR, odds ratio; CI, confidence interval; Tdap, tetanus,
diphtheria, and acellular pertussis; and HPV, human papillomavirus.
∗
Shown are raw frequencies and weighted estimates. Models controlled for
child's race/ethnicity, mother's educational attainment, and annual household
income. Dashes indicate that findings are not presented because analyses did
not yield statistically significant associations.
†
HPV refusal was assessed only for girls (n = 3547). The model excluded
parents (n = 745) who had missing data on HPV vaccine refusal.
Compared to overall confidence scores, scores for the Benefits factor alone
were somewhat more strongly associated with any vaccine refusal (OR, 0.94; 95%
CI, 0.93–0.95) as well as with refusal of Tdap, meningococcal, and HPV vaccines.
Factor scores for Harms were positively associated with refusal of any vaccine,
Tdap, and HPV vaccine, but not meningococcal vaccine. Factor scores for Trust were
not associated with any of the 4 refusal measures.

Vaccine Delay
Over one-fifth of parents (22%) reported having delayed any vaccine for
their child, with vaccine-specific delay ranging from 11% for HPV vaccine (girls
only) to 7% for meningococcal vaccine to 4% for Tdap. Overall confidence scores
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were weakly associated with delay of any vaccine (OR, 0.99; 95% CI, 0.99–1.00),
Tdap (OR, 0.97; 95% CI, 0.96–0.98), and meningococcal vaccines (OR, 0.98; 95%
CI, 0.97–0.98), but not HPV vaccine. Factor scores for Benefits were also
associated with delay of any vaccine (OR, 0.99; 95% CI, 0.98–1.00) and Tdap (OR,
0.95; 95% CI, 0.93–0.97). Factor scores for Harms were associated with delay of
meningococcal vaccine only (OR, 1.06; 95% CI, 1.04–1.09). Factor scores for Trust
were not associated with any of the 4 delay measures.

Vaccination Status
Provider-reported vaccination coverage was highest for Tdap (83%) and
meningococcal vaccines (66%), with a smaller proportion of girls having initiated
(52%) or completed (37%) the HPV vaccine series (Table 3). Overall confidence
scores were positively associated with all 4 measures of vaccination status, with the
magnitude of the association being highest for HPV vaccine initiation (OR, 1.52;
95% CI, 1.31–1.68) and lowest for Tdap vaccination (OR, 1.20; 95% CI, 1.11–
1.30). Factor scores for Benefits were also associated with each measure of
vaccination status, although not as strongly as overall scores. Factor scores for
Harms were associated with meningococcal vaccination and HPV vaccine initiation.
Factor scores for Trust were associated with meningococcal vaccination only.
Table 3. Provider-Reported Vaccination Status: Multivariable Associations With
Scale and Factor Score Means (n = 7173)∗
Scale
Vaccinated
Characteristic
n (%)

(8 items)
Mean
(SE)

OR
(95%
CI)

Factors
Benefits (4
items)
Mean
(SE)

OR
(95%
CI)

Harms (2
items)
Mean
(SE)

OR
(95%
CI)

Trust (2 items)
Mean
(SE)

OR
(95%
CI)

Tdap
Yes

5969 (83%)

1.20
8.30
(1.11,
(0.03)
1.30)

1.20
8.63
(1.12,
(0.04)
1.28)

No

1204 (17%)

7.92
8.13
3.53
Reference
Reference
(0.08)
(0.10)
(0.13)

3.19
—
(0.06)

9.16
—
(0.03)
8.97
(0.06)

Meningococcal
Yes

1.31
8.41
4766 (66%)
(1.22,
(0.04)
1.39)

No

2407 (34%)

1.17
8.72
(1.09,
(0.04)
1.26)

0.96
3.05
(0.92,
(0.07)
1.00)

1.09
9.24
(1.01,
(0.04)
1.18)

7.89
8.17
3.65
8.89
Reference
Reference
Reference
Reference
(0.05)
(0.07)
(0.09)
(0.05)
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Scale
Vaccinated
Characteristic
n (%)

(8 items)
Mean
(SE)

OR
(95%
CI)

Factors
Benefits (4
items)
Mean
(SE)

OR
(95%
CI)

Harms (2
items)
Mean
(SE)

OR
(95%
CI)

Trust (2 items)
Mean
(SE)

OR
(95%
CI)

HPV (≥1
dose)†
Yes

1778 (52%)

1.52
8.57
(1.38,
(0.05)
1.68)

1.36
8.94
(1.24,
(0.05)
1.49)

0.93
2.95
(0.88,
(0.10)
0.99)

No

1641 (48%)

7.87
8.16
3.79
8.96
Reference
Reference
Reference
(0.06)
(0.08)
(0.10)
(0.07)

Yes

1253 (37%)

1.46
8.61
(1.31,
(0.06)
1.64)

No

2166 (63%)

8.01
8.30
3.60
Reference
Reference
(0.05)
(0.07)
(0.09)

9.34
—
(0.04)

HPV (3 doses)†
1.41
9.01
(1.28,
(0.06)
1.55)

2.93
—
(0.12)

9.38
—
(0.05)
9.03
(0.06)

SE indicates standard error; OR, odds ratio; CI, confidence interval; Tdap, tetanus,
diphtheria, and acellular pertussis; and HPV, human papillomavirus.
∗
Models controlled for child's race/ethnicity, mother's educational attainment,
and annual household income. Dashes indicate that findings are not
presented because analyses did not yield statistically significant associations.
†
HPV coverage assessed only for girls (n = 3419).

Factor Comparison and Thresholds
Factor Comparison
On the basis of the validation analyses, we identified the Benefits factor as
having the strongest factor-specific performance. Compared to scores on the full
scale, which were associated with 11 of the 12 validation measures of vaccine
refusal, delay, and vaccination status, scores on the Benefits factor alone were
associated with 10 measures, and the magnitudes of the associations were
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comparable in most cases. By comparison, scores on Harms were associated with 6
validation measures, and scores on Trust were associated with only 1 measure. On
the basis of these findings, we assessed the Benefits factor in subsequent analyses
as a short form of our scale.

Thresholds
A graph of prevalence of any vaccine refusal by confidence scale scores
suggested a sharp decrease in prevalence for scores greater than 6 with a smaller
decrease for scores greater than 8 (Fig. 2). A graph of factors scores for the 4-item
Benefits factor followed a similar pattern. On the basis of this analysis, we
categorized overall and individual factor scores as low (≤6), medium (>6 to 8), or
high (>8).

1. Download high-res image (117KB)
2. Download full-size image
Figure 2. Vaccination confidence thresholds for mean scale and factor scores.
Confidence categories were associated with vaccine refusal in the expected
order. Parents with medium versus high confidence had about 2 times higher odds
of reporting any refusal (OR, 2.08; 95% CI, 1.75–2.47) (Table 4). Parents with low
versus high confidence had over 4 times higher odds of reporting any refusal (OR,
4.61; 95% CI, 3.51–6.05). Categories for the Benefits factor alone demonstrated
similar, although slightly weaker, associations such that refusal of any vaccine was
more common among parents whose scale scores were medium (OR, 1.99; 95%
CI, 1.65–2.40) or low (OR, 4.07; 95% CI, 3.11–5.34) versus high.
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Table 4. Parent-Reported Refusal of Any Vaccine: Associations With Scale and
Factor Categories (n = 9018)∗
Scale (8 items)
Mean Score

Refused, n
(%)

Benefits Factor (4 items)
Refused, n
(%)

OR (95% CI)

OR (95% CI)

318 (49)

4.61 (3.51,
6.05)

358 (47)

4.07 (3.11,
5.34)

Medium (>6 to
861 (30)
8)

2.08 (1.75,
2.47)

641 (31)

1.99 (1.65,
2.40)

High (>8)

Reference

1187 (18)

Reference

Low (≤6)

1007 (17)

CI indicates confidence interval; and OR, odds ratio.
∗
Data are presented as raw frequencies and weighted estimates.

Discussion
Using data from a large, population-based sample of parents, we found that
mean scores on the Vaccination Confidence Scale were consistently associated with
vaccine refusal and vaccination status across the adolescent platform. Associations
were larger in magnitude for vaccination status than vaccine refusal, with
vaccination confidence showing a particularly strong association with having
initiated or completed the HPV vaccine series. For example, for every 1-point
increase in parents' mean scale scores, adolescents had over 50% greater odds of
having received at least 1 dose of HPV vaccine. Our threshold analyses further
demonstrated a gradient between confidence and prevalence of vaccine refusal,
with parents in the low versus high confidence category having over 4 times the
odds of reporting any refusal. Overall, these findings provide strong support for the
validity of the Vaccination Confidence Scale as a measure of vaccination beliefs
associated with vaccine refusal and vaccination status among adolescents.
We found that mean scale scores were only weakly and inconsistently
associated with measures of vaccine delay. This finding may reflect a shortcoming
of our measures of delay, which did not distinguish between intentional delays and
those that were medically indicated. Alternatively, compared to vaccine refusal,
vaccine delay may simply be less closely linked with parents' confidence in
adolescent vaccines; issues such as cost, convenience, or strength of a provider's
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recommendation may instead be more salient factors.6,16,17 Given that vaccine delay
is associated with underimmunization and is particularly common with regard to
HPV vaccination,6 future studies should seek to better understand beliefs associated
with this behavior.
In terms of applications, our findings provide support for using the
Vaccination Confidence Scale to identify populations of parents at risk for refusing
adolescent vaccines. Such a tool is useful based on research indicating that parents'
informational needs vary according to whether and how much they are hesitant to
vaccinate their children.18,19 Using the cut points we have established for our scale,
researchers can stratify study samples to assess the differential impact of messages
and other interventions by vaccination confidence. In contrast to these and other
population-level research applications, the utility of our scale as a clinical screening
tool for identifying individual parents at risk for vaccine refusal is less clear; before
the scale could be used in this way, additional research will be needed to assess its
sensitivity and specificity as well as the feasibility of integrating such a measure
into clinical care. Future work is also needed to further establish the predictive
validity of the Vaccination Confidence Scale by prospectively assessing the
relationship between vaccination confidence and subsequent behavior.
We were interested to find that the 4-item Benefits factor demonstrated
comparable performance to the full 8-item scale. Compared to the full scale, mean
scores for Benefits were slightly more strongly associated with measures of vaccine
refusal and less strongly associated with vaccination status. In contrast, the Harms
and Trust factors were inconsistently associated with these measures. These
findings suggest that perceived benefits are particularly important to understanding
parents' vaccination behavior.20–22 Indeed, prior studies in health communication
have found that messages about benefits can increase parents' intentions to
vaccinate, particularly when those messages emphasize the potential loss of
benefits.23,24 From a measurement perspective, the successful validation of the
Benefits factor suggests that it can be used as a short form of the Vaccination
Confidence Scale, thereby increasing the utility of our measure in the context of
national surveys or other research activities for which cost and participant burden
must be strictly managed.
Strengths of our study include the use of a large, nationally representative
sample of parents and provider-reported data on vaccination status. To our
knowledge, this study is the first to validate a measure of vaccination beliefs with
regard to the behavior of vaccine refusal, which is important as a specific and
potentially modifiable antecedent to vaccination status. Limitations to this study
include its cross-sectional design, which prevents us from assessing the
directionality of the relationship between vaccination confidence and behavior. In
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addition, our sample consisted of parents of 13- to 17-year-old children, whereas
practice guidelines recommend 11- to 12-year-old children for the routine
administration of adolescent vaccines. Although our analyses yielded no evidence to
suggest that the relationship between vaccination confidence and refusal, delay, or
vaccination status varied by child's age, our findings will need to be replicated with
regard to younger children. Future studies should also investigate subgroup
variation in the association between vaccination confidence and vaccine refusal as
well as the potential for using the Vaccination Confidence Scale to identify
populations at risk for refusing other vaccines, including those administered in early
childhood and HPV vaccine when administered to boys.

Conclusions
The Vaccination Confidence Scale shows promise as a tool for identifying
parents at risk for refusing adolescent vaccines. Mean scores on the 8-item scale
were associated with vaccine refusal and vaccination status across the adolescent
platform, and items assessing the perceived benefits of vaccination performed
especially well. Indeed, our findings suggest that the 4-item Benefits factor can
serve as a short form for our scale, thereby halving its length, with only small
trade-offs in performance. As a very brief measure validated with respect to vaccine
refusal, the Vaccination Confidence Scale can usefully extend our arsenal of
measurement tools for assessing, and in turn intervening to improve, vaccination
beliefs. Given that almost one-quarter of parents in our sample reported having
refused vaccines for their children, our findings underscore the importance of these
efforts.
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